Hermetica Superfood Encyclopedia
The Short Answer
5-LOXIN is a standardized Boswellia serrata extract containing 30% AKBA (3-O-acetyl-11-keto-β-boswellic acid) that inhibits 5-lipoxygenase enzyme activity. This selective inhibition reduces inflammatory mediators like leukotrienes, providing targeted joint pain relief and cartilage protection.
CategoryBranded Ingredient
GroupBranded Anti-Inflammatory
Evidence LevelStrong
Primary Keyword5-LOXIN benefits
Synergy Pairings5
5-LOXIN (Boswellia, 30% AKBA) — botanical close-up
Health Benefits
5-LOXIN provides potent anti-inflammatory effects by inhibiting the 5-lipoxygenase enzyme, reducing joint pain and swelling. This can improve mobility and quality of life. - It supports joint health by maintaining cartilage integrity and reducing degradation. Healthy cartilage is crucial for pain-free movement. - 5-LOXIN enhances respiratory health by reducing inflammation in the airways. This can alleviate symptoms of asthma and improve breathing. - It supports digestive health by reducing inflammation in the gut lining. A healthy gut lining can prevent conditions like IBS. - 5-LOXIN promotes cardiovascular health by improving endothelial function. Enhanced endothelial function can lower blood pressure and reduce heart disease risk. - It aids in skin health by reducing inflammation and promoting collagen production. This can result in firmer, more youthful skin. - 5-LOXIN supports mental health by reducing neuroinflammation. Lower neuroinflammation can improve cognitive function and reduce the risk of neurodegenerative diseases.
Origin & History
Natural habitat
5-LOXIN is a branded extract of Boswellia serrata, standardized to contain 30% acetyl-11-keto-beta-boswellic acid (AKBA). It is produced through a specialized extraction process that concentrates the active components.
“Boswellia, also known as frankincense, has been used in traditional Ayurvedic medicine for its anti-inflammatory properties. It holds cultural and religious significance in various ancient civilizations.”Traditional Medicine
Scientific Research
Clinical studies have demonstrated that 5-LOXIN effectively reduces inflammation and joint pain. RCTs and meta-analyses support its use in improving joint function and reducing symptoms of osteoarthritis.
Preparation & Dosage
Traditional preparation
Typical dosages range from 100 mg to 250 mg per day. Consult a healthcare provider before use.
Nutritional Profile
How It Works
Mechanism of Action
5-LOXIN's primary bioactive compound AKBA selectively inhibits 5-lipoxygenase (5-LOX) enzyme, blocking the conversion of arachidonic acid to inflammatory leukotrienes. This inhibition reduces pro-inflammatory mediators LTB4 and 5-HETE while preserving beneficial cyclooxygenase pathways. The extract also modulates NF-κB signaling and inhibits matrix metalloproteinases that degrade cartilage collagen.
Clinical Evidence
Human trials with 5-LOXIN have shown significant improvements in joint function and pain reduction. A 90-day study with 60 osteoarthritis patients using 100mg daily demonstrated 65% improvement in pain scores and 61% improvement in joint function compared to placebo. Additional studies indicate onset of benefits within 7 days of supplementation. However, most clinical data comes from small-scale trials requiring larger confirmatory studies.
Safety & Interactions
5-LOXIN is generally well-tolerated with mild gastrointestinal upset reported in some users. It may enhance the effects of anti-inflammatory medications and blood thinners due to its anti-platelet properties. Individuals with bleeding disorders or those taking anticoagulant medications should consult healthcare providers before use. Safety during pregnancy and lactation has not been established, so use should be avoided during these periods.
Synergy Stack
Hermetica Formulation Heuristic
Frequently Asked Questions
What is the optimal dosage of 5-LOXIN for joint pain?
Clinical studies typically use 100-250mg of 5-LOXIN daily, standardized to 30% AKBA. Most research shows 100mg daily provides significant joint pain relief within 7-30 days of consistent use.
How long does it take for 5-LOXIN to work?
5-LOXIN can provide initial pain relief within 7 days, with maximum benefits typically observed after 30-90 days of consistent use. Some users report improved mobility and reduced morning stiffness within the first two weeks.
What makes 5-LOXIN different from regular Boswellia?
5-LOXIN is standardized to contain 30% AKBA, the most potent anti-inflammatory compound in Boswellia. Regular Boswellia extracts typically contain only 2-10% AKBA, making 5-LOXIN significantly more concentrated and effective.
Can 5-LOXIN be taken with other joint supplements?
5-LOXIN can generally be combined with glucosamine, chondroitin, and MSM safely. However, combining with other anti-inflammatory supplements like curcumin or fish oil may increase bleeding risk and should be monitored by a healthcare provider.
Does 5-LOXIN help with conditions other than joint pain?
Research suggests 5-LOXIN may benefit inflammatory bowel conditions and respiratory inflammation due to its 5-lipoxygenase inhibition. However, most clinical evidence focuses on osteoarthritis and joint health applications, with other uses requiring more research.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
